1. Home
  2. TIL vs DUOT Comparison

TIL vs DUOT Comparison

Compare TIL & DUOT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Instil Bio Inc.

TIL

Instil Bio Inc.

HOLD

Current Price

$11.32

Market Cap

177.1M

Sector

Health Care

ML Signal

HOLD

Logo Duos Technologies Group Inc.

DUOT

Duos Technologies Group Inc.

HOLD

Current Price

$10.11

Market Cap

180.9M

Sector

Technology

ML Signal

HOLD

Company Overview

Basic Information
Metric
TIL
DUOT
Founded
2018
1990
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Computer Software: Prepackaged Software
Sector
Health Care
Technology
Exchange
Nasdaq
Nasdaq
Market Cap
177.1M
180.9M
IPO Year
2021
N/A

Fundamental Metrics

Financial Performance
Metric
TIL
DUOT
Price
$11.32
$10.11
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
5
2
Target Price
$100.67
$12.75
AVG Volume (30 Days)
73.2K
287.1K
Earning Date
11-13-2025
11-12-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
$19,026,308.00
Revenue This Year
N/A
$292.26
Revenue Next Year
N/A
$43.21
P/E Ratio
N/A
N/A
Revenue Growth
N/A
159.00
52 Week Low
$10.70
$3.84
52 Week High
$42.79
$11.23

Technical Indicators

Market Signals
Indicator
TIL
DUOT
Relative Strength Index (RSI) 38.95 55.89
Support Level $10.76 $9.54
Resistance Level $11.51 $11.20
Average True Range (ATR) 0.88 0.59
MACD 0.15 0.02
Stochastic Oscillator 24.64 64.84

Price Performance

Historical Comparison
TIL
DUOT

About TIL Instil Bio Inc.

Instil Bio Inc is a clinical-stage biopharmaceutical company focused on developing a cell therapy pipeline of autologous tumor infiltrating lymphocyte, or TIL, therapies for the treatment of patients with cancer. It is also engaged in developing a novel class of genetically engineered TIL therapies using its Co-Stimulatory Antigen Receptor, or CoStAR, platform. Its pipeline includes ITIL-306 which expresses a CoStAR molecule designed to recognize, a tumor-associated antigen that is expressed on numerous solid tumors, including ovarian cancer, uterine cancer, NSCLC, and renal cancer.

About DUOT Duos Technologies Group Inc.

Duos Technologies Group Inc operating under its brand name duostech, designs, develops, deploys and operates intelligent technology solutions supporting rail, logistics and intermodal businesses that streamline operations, improve safety and reduce costs. The company's main offering, the Railcar Inspection Portal (RIP), provides both freight and transit railroad customers and select government agencies the ability to conduct fully automated railcar inspections of trains that are moving at full speed. It has also developed the Automated Logistics Information System (ALIS) which automates gatehouse operations where transport trucks enter and exit large logistics and intermodal facilities. Its segments are Rail, Commercial, Governments, Banking and AI.

Share on Social Networks: